The impact of selected cytokines in the follow-up of normal pressure hydrocephalus.

Cytokines are widely known mediators of inflammation accompanying many neurodegenerative disorders including normal pressure hydrocephalus (NPH). NPH is caused by impaired cerebrospinal fluid (CSF) reabsorption and treated by surgical shunt insertion. The diagnostics is still complicated and the shunt effect is not durable; after several years, dementia may develop. In the clinical practice, biomarkers support the diagnostics as well as the further time course of many neurodegenerative diseases. Until recently, no reliable biomarker for NPH was evaluated. The attempt of this review was to make a survey concerning cytokines as possible NPH markers. Among all reviewed cytokines, the most promising are CSF IL-10 and IL-33, enabling to follow-up the disease progression and monitoring the effectiveness of the shunt insertion.

[1]  R. Hampl,et al.  Hormones and the blood-brain barrier , 2015, Hormone molecular biology and clinical investigation.

[2]  P. Gallo,et al.  Cerebrospinal fluid IL-1β correlates with cortical pathology load in multiple sclerosis at clinical onset , 2014, Journal of Neuroimmunology.

[3]  Ingmar Skoog,et al.  Prevalence of idiopathic normal-pressure hydrocephalus , 2014, Neurology.

[4]  H. Soininen,et al.  Cerebrospinal Fluid Biomarker and Brain Biopsy Findings in Idiopathic Normal Pressure Hydrocephalus , 2014, PloS one.

[5]  G. Caldito,et al.  Long-term outcomes of ventriculoperitoneal shunt surgery in patients with hydrocephalus. , 2014, World neurosurgery.

[6]  K. Ishii,et al.  Predictors of the disappearance of triad symptoms in patients with idiopathic normal pressure hydrocephalus after shunt surgery , 2013, Journal of the Neurological Sciences.

[7]  山本 大介.  Association between milder brain deformation before a shunt operation and improvement in cognition and gait in idiopathic normal pressure hydrocephalus , 2013 .

[8]  Teruhiko Higuchi,et al.  Increased cerebrospinal fluid interleukin-6 levels in patients with schizophrenia and those with major depressive disorder. , 2013, Journal of psychiatric research.

[9]  W. Jin,et al.  IL-17 cytokines in immunity and inflammation , 2013, Emerging Microbes & Infections.

[10]  James C. Cronk,et al.  IL-4 in the Brain: A Cytokine To Remember , 2012, The Journal of Immunology.

[11]  J. Morillas-Ruiz,et al.  A Review: Inflammatory Process in Alzheimer's Disease, Role of Cytokines , 2012, TheScientificWorldJournal.

[12]  P. Black,et al.  Cerebrospinal Fluid Biomarkers in Idiopathic Normal Pressure Hydrocephalus , 2011, International journal of Alzheimer's disease.

[13]  G. Ladurner,et al.  Cytokine and Growth Factor Concentration in Cerebrospinal Fluid from Patients with Hydrocephalus Following Endovascular Embolization of Unruptured Aneurysms in Comparison with Other Types of Hydrocephalus , 2010, Neurochemical Research.

[14]  Anirban Basu,et al.  Inflammasome signaling at the heart of central nervous system pathology , 2010, Journal of neuroscience research.

[15]  I. McInnes,et al.  Disease-associated functions of IL-33: the new kid in the IL-1 family , 2010, Nature Reviews Immunology.

[16]  P. Eide,et al.  Five‐year incidence of surgery for idiopathic normal pressure hydrocephalus in Norway , 2009, Acta neurologica Scandinavica.

[17]  Takeo Kato,et al.  Asymptomatic ventriculomegaly with features of idiopathic normal pressure hydrocephalus on MRI (AVIM) in the elderly: A prospective study in a Japanese population , 2009, Journal of the Neurological Sciences.

[18]  V. Perry,et al.  Systemic Inflammation Induces Acute Behavioral and Cognitive Changes and Accelerates Neurodegenerative Disease , 2009, Biological Psychiatry.

[19]  C. Sasakawa,et al.  Differential roles of interleukin-17A and -17F in host defense against mucoepithelial bacterial infection and allergic responses. , 2009, Immunity.

[20]  B. Jin,et al.  Interleukin-10 endogenously expressed in microglia prevents lipopolysaccharide-induced neurodegeneration in the rat cerebral cortex in vivo , 2007, Experimental & Molecular Medicine.

[21]  N. Rothwell,et al.  Interleukin-1 and inflammatory neurodegeneration. , 2007, Biochemical Society transactions.

[22]  M. Miyajima,et al.  Expression of TGF-βs and TGF-β type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus , 2007, Neuroscience Letters.

[23]  N. Kitchen,et al.  Biomarkers in chronic adult hydrocephalus , 2006, Cerebrospinal Fluid Research.

[24]  B. Bergamasco,et al.  Increased intrathecal TGF-β1, but not IL-12, IFN-γ and IL-10 levels in Alzheimer’s disease patients , 2006, Neurological Sciences.

[25]  J Fernando Bazan,et al.  IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. , 2005, Immunity.

[26]  Ying Wang,et al.  A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17 , 2005, Nature Immunology.

[27]  Marvin Bergsneider,et al.  Diagnosing Idiopathic Normal-pressure Hydrocephalus , 2005, Neurosurgery.

[28]  R. Shivers,et al.  Structural pathways for macromolecular and cellular transport across the blood-brain barrier during inflammatory conditions. Review. , 2004, Histology and histopathology.

[29]  K. Książek,et al.  Interleukin-17: a mediator of inflammatory responses , 2004, Cellular and Molecular Life Sciences CMLS.

[30]  M. Tullberg,et al.  Normal pressure hydrocephalus triggers intrathecal production of TNF-α , 2003, Neurobiology of Aging.

[31]  N. Rothwell.  Interleukin-1 and neuronal injury: mechanisms, modification, and therapeutic potential , 2003, Brain, Behavior, and Immunity.

[32]  Tony Wyss-Coray,et al.  Inflammation in Neurodegenerative Disease—A Double-Edged Sword , 2002, Neuron.

[33]  A. Weverling-Rijnsburger,et al.  Patients with Alzheimer's disease display a pro-inflammatory phenotype , 2001, Experimental Gerontology.

[34]  N. Rothwell,et al.  Interleukin 1 in the brain: biology, pathology and therapeutic target , 2000, Trends in Neurosciences.

[35]  T. Marunouchi,et al.  Interleukin‐10 Inhibits Both Production of Cytokines and Expression of Cytokine Receptors in Microglia , 1999, Journal of neurochemistry.

[36]  Yulan He,et al.  IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages. , 1998, Journal of immunology.

[37]  T. Nagatsu,et al.  Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease , 1996, Neuroscience Letters.

[38]  Peter Riederer,et al.  Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients , 1995, Neuroscience Letters.

[39]  T. Krakauer.  IL-10 inhibits the adhesion of leukocytic cells to IL-1-activated human endothelial cells. , 1995, Immunology letters.

[40]  T. Tada,et al.  Elevation of Transforming Growth Factor‐&bgr;1 Level in Cerebrospinal Fluid of Patients With Communicating Hydrocephalus After Subarachnoid Hemorrhage , 1994, Stroke.

[41]  H. von Holst,et al.  Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. , 1993, Journal of neurosurgery.

[42]  S. Akira,et al.  Interleukin-6 and its receptor: a paradigm for cytokines. , 1992, Science.

[43]  R. Thompson,et al.  Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today (Amsterdam. Regular ed.).

[44]  M. Barquero,et al.  Cerebrospinal fluid interleukin-1 beta (IL-1 beta) in Alzheimer's disease and neurological disorders. , 1991, Methods and findings in experimental and clinical pharmacology.

[45]  P. Hart,et al.  Potential antiinflammatory effects of interleukin 4: suppression of human monocyte tumor necrosis factor alpha, interleukin 1, and prostaglandin E2. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. Northfield.  Cerebrospinal Fluid Pressure , 1953 .

[47]  R. Hampl,et al.  Selected pro- and anti-inflammatory cytokines in cerebrospinal fluid in normal pressure hydrocephalus. , 2014, Neuro endocrinology letters.

[48]  H. Soininen,et al.  Poor cognitive outcome in shunt-responsive idiopathic normal pressure hydrocephalus. , 2013, Neurosurgery.

[49]  M. Miyajima,et al.  Expression of TGF-betas and TGF-beta type II receptor in cerebrospinal fluid of patients with idiopathic normal pressure hydrocephalus. , 2007, Neuroscience letters.

[50]  B. Bergamasco,et al.  Increased intrathecal TGF-beta1, but not IL-12, IFN-gamma and IL-10 levels in Alzheimer's disease patients. , 2006, Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology.

[51]  Jau-Shyong Hong,et al.  Role of microglia in inflammation-mediated degeneration of dopaminergic neurons: neuroprotective effect of interleukin 10. , 2006, Journal of neural transmission. Supplementum.

[52]  石津 尚明.  Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis , 2006 .

[53]  M. Tullberg,et al.  Normal pressure hydrocephalus triggers intrathecal production of TNF-alpha. , 2003, Neurobiology of aging.

[54]  C. Janeway,et al.  An Introduction to Immunobiology and Innate Immunity , 2001 .